Emerald Advisers »

Intra Cellular Therapies shares owned by Emerald Advisers

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $37M 438k 83.52
2024-09-30 $32M 441k 73.17
2024-06-30 $27M 393k 68.49
2024-03-31 $28M 402k 69.20
2023-12-31 $25M 344k 71.62
2023-09-30 $20M 382k 52.09
2023-06-30 $21M 335k 63.32

More positions owned by Emerald Advisers

Kratos Defense & Security Solutions (KTOS)
Credo Technology Group Holding (CRDO)
AeroVironment (AVAV)
Rambus (RMBS)
Lumentum Hldgs (LITE)
TTM Technologies (TTMI)
Bloom Energy Corp (BE)
Modine Manufacturing (MOD)
Guardant Health (GH)
Varonis Sys (VRNS)
Travere Therapeutics (TVTX)
RadNet (RDNT)
Sitime Corp (SITM)
National Vision Hldgs (EYE)
Ban (TBBK)

View all positions for Emerald Advisers

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies